Atrys Health, S.A. (BME:ATRY) signed an agreement to acquire Genetyca on June 7, 2021. The transaction will be financed with the company's own resources and does not involve the issuance of new Atrys shares. The transaction is expected to be completed before June 30, 2021. Atrys Health, S.A. (BME:ATRY) completed the acquisition of GENETYCA – ICM, S.A. on September 1, 2021.